Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis
Clinical trial NCT05297448 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05297448
- Sponsor
- Bausch Health Americas, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-03
- Primary completion
- 2026-01-01
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.